Arcadia Biosciences, Inc. (RKDA) Operating cash flow 2017–2026
Arcadia Biosciences, Inc. (RKDA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$4.7MFY2026 · since FY2017: -$17.1M → -$4.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$4.7M | +51.2% |
| FY2025 | -$9.6M | +37.1% |
| FY2024 | -$15.3M | -9.4% |
| FY2023 | -$14.0M | +46.0% |
| FY2022 | -$25.9M | +14.4% |
| FY2021 | -$30.2M | -75.7% |
| FY2020 | -$17.2M | -26.2% |
| FY2019 | -$13.6M | +2.4% |
| FY2018 | -$14.0M | +18.1% |
| FY2017 | -$17.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RKDA financial trends
RKDA RevenueRKDA Net incomeRKDA Net marginRKDA Gross profitRKDA Gross marginRKDA Operating incomeRKDA Operating marginRKDA Free cash flowRKDA Capital expendituresRKDA Return on equityRKDA Stock buybacksRKDA Dividends paidRKDA Total assetsRKDA Total liabilitiesRKDA Shareholders’ equityRKDA overview →